Baird Reiterates Outperform on Instil Bio, Maintains $54 Price Target
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Jack Allen has reiterated an Outperform rating on Instil Bio (NASDAQ:TIL) and maintained a price target of $54.
January 19, 2024 | 7:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst Jack Allen reaffirmed an Outperform rating on Instil Bio with a price target of $54, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a Baird analyst suggests a bullish stance on Instil Bio's stock. The maintained price target of $54 implies a potential upside from the current trading price, assuming the stock is trading below this target. This could lead to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100